According to the NCI website, cinrebafusp alfa is a bivalent, bispecific fusion protein comprised of an anti-human epidermal growth factor receptor (HER2) monoclonal antibody linked to a CD137-targeting anticalin with potential immunostimulatory and antineoplastic activities. Check for active clinical trialsusing this agent. (NCI Thesaurus)

More Information in English:

Inxight: Drugs (NIH)

AdisInsight
Link to National Cancer Institute